Clinical trial Recruiting at 1 site Observational Ages 18 and up

Drug absorption in people with an ostomy

Official title: Beeinflussung Der Resorption Von Arzneimitteln Bei Stoma Patient*Innen

Run by WiGeV Klinik Ottakring · NCT07138326 · Data updated 2026-11-12

This study will test whether commonly used psychotropic medicines and newer oral blood thinners reach expected levels in adults who have an ileostomy or colostomy.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment128 (estimated)
SponsorWiGeV Klinik Ottakring
Academic / other
Locations1 site (Vienna, State of Vienna)
StatusRecruiting
StartedJune 18, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 22, 2025
Trial IDNCT07138326 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with an ileostomy or colostomy in place for at least seven days who have been taking one or more of the listed psychotropic drugs or NOACs for at least seven days are eligible.

Probably not a fit

People who are not taking any of the listed medications, who had their stoma placed fewer than seven days ago, or who cannot communicate due to an insurmountable language barrier are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational monitoring project at a single center in Vienna that follows adults with an ileostomy or colostomy who have had their stoma for at least seven days. Participants must have been taking one or more specified psychotropic drugs or a NOAC for at least seven days, and the team will use blood tests and, where applicable, clinical measures (for example blood pressure or blood sugar) to determine absorption. The goal is to determine whether therapeutic drug levels are achieved in ostomy patients, addressing a gap left by approval studies and limited case reports. Results will help clarify whether dosing or monitoring practices should differ for people with stomas.

Why it matters

Potential benefit: If successful, the findings could help clinicians know when medications need different dosing or closer monitoring in ostomy patients to ensure effectiveness and safety.

How similar studies have gone: Previous evidence consists mainly of case reports and very small patient series, so systematic, larger data are limited and this approach is not yet well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Planned inclusion criteria:

* Male and female patients aged ≥18 years
* Belonging to a collective
* Ileostomy since ≥7d
* Colostomy since ≥7d The stoma must have been inserted at least 7d ago to ensure that a steady state concentration is achieved.
* Taking ≥1 of the following active substances since ≥7d:

  * Psychotropic drugs: citalopram, clozapine, duloxetine, escitalopram, melperone, mianserin, milnacipran, mirtazapine, olanzapine, paliperidone, paroxetine, pregabalin, prothipendyl, quetiapine, risperidone, sertraline, trazodone, venlafaxine
  * NOACs: edoxaban, rivaroxban, apixaban

Exclusion Criteria:

Insurmountable language barrier

Where it's running

  • WiGeV Klinik Ottakring
    Vienna, State of Vienna, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.